DMII — Drugs Made In America Acquisition II Corp.
Price · 2025-12-03 → 2026-08-21
180 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2025-12-03.
Performance
Technicals
Measured signals that fired on DMII
| date | signal | measured base rate |
|---|---|---|
| 2026-06-25 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-04-30 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-02-26 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2025-09-26 | Do Catherine Director | Other Acquisition/Disposition | 100.0K | — | — |
| 2025-09-26 | Shulgan Myron W. Director | Other Acquisition/Disposition | 100.0K | — | — |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | Open-market purchase | 700.0K | — | — |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | Other Acquisition/Disposition | 400.0K | — | — |
| 2025-09-26 | Drugs Made In America Acquisition II LLC | Open-market sale | 8.0M | — | — |
| 2025-09-26 | Worman Glenn C. CFO | Other Acquisition/Disposition | 100.0K | — | — |
| 2025-09-26 | Prasad Sridhar G. Director | Other Acquisition/Disposition | 100.0K | — | — |
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Open-market purchase | 700.0K | — | — |
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Open-market sale | 8.0M | — | — |
| 2025-09-26 | Stockwell Lynn CEO and Exe. Chair of Board | Other Acquisition/Disposition | 400.0K | — | — |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Magnetar Financial LLC | 26.9M | 2.7M |
| MMCAP International Inc. SPC | 26.9M | 2.7M |
| Karpus Management, Inc. | 25.9M | 2.6M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 20.0M | 2.0M |
| MILLENNIUM MANAGEMENT LLC | 19.7M | 2.0M |
| Hudson Bay Capital Management LP | 19.7M | 2.0M |
| WOLVERINE ASSET MANAGEMENT LLC | 17.9M | 1.8M |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 15.0M | 1.5M |
| Polar Asset Management Partners Inc. | 15.0M | 1.5M |
| D. E. Shaw & Co., Inc. | 13.9M | 1.4M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | on EDGAR ↗ |
| 8-K | 2026-04-28 | 2026-04-22 | on EDGAR ↗ |
| 10-K | 2026-04-15 | 2025-12-31 | on EDGAR ↗ |
| 8-K | 2026-04-03 | 2026-03-24 | on EDGAR ↗ |
| NT 10-K | 2026-04-01 | 2025-12-31 | on EDGAR ↗ |
| 8-K | 2026-03-17 | 2026-03-11 | on EDGAR ↗ |
| 8-K | 2026-03-06 | 2026-03-06 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Ask the AI about DMII
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →